Trial Profile
Proactive management with topical corticosteroids ointment in pediatric atopic dermatitis : Superiority to rank-down therapy
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 08 Jul 2019
Price :
$35
*
At a glance
- Drugs Betamethasone butyrate propionate (Primary)
- Indications Atopic dermatitis
- Focus Therapeutic Use
- 05 Jul 2019 According to UMIN, the date for data entry closure is 28th Feb 2019, the date for conclusion of data analysis is 31st Dec 2019.
- 05 Jul 2019 Status changed from not yet recruiting to discontinued.
- 03 Apr 2018 New trial record